Targets visceral fat
Specifically reduces abdominal visceral adipose tissue through enhanced lipolysis.
Tesamorelin is administered as a daily subcutaneous injection, typically in the abdominal area. The standard dose is 2mg per day. Treatment duration and adjustments are determined by your provider based on your response and health goals.
All dosing is determined by your licensed provider based on your health profile.
Do not self-administer without medical supervision.
Tesamorelin
FDA-studied GHRH analog for visceral fat reduction and metabolic health.
Starting at
$179/month
All plans include doctor review, personalized treatment plan, and 24/7 provider access.
Unlimited 24/7 support
No hidden fees
No insurance required
Same price, every dose
Tesamorelin is administered as a daily subcutaneous injection, typically in the abdominal area. The standard dose is 2mg per day. Treatment duration and adjustments are determined by your provider based on your response and health goals.
All dosing is determined by your licensed provider based on your health profile. Do not self-administer without medical supervision.
- Dose
- 2mg/day
- Target
- Visceral adipose tissue
- Form
- Injectable peptide
- Availability
- Prescription only
Tesamorelin is specifically designed and studied for visceral fat reduction. Unlike general GH secretagogues, it has been evaluated in large-scale clinical trials with FDA oversight, providing a robust evidence base for its metabolic benefits.
Tesamorelin has received FDA approval for the reduction of excess abdominal fat in specific clinical populations. When prescribed by Peppy providers, it is compounded for individual patient use based on clinical assessment.
Clinical trials showed measurable reductions in visceral fat within 12-26 weeks of consistent daily use. Individual results vary based on factors including diet, exercise, and baseline health status.
How Tesamorelin works
Tesamorelin is a synthetic analog of growth hormone releasing hormone (GHRH) with a trans-3-hexenoic acid modification that enhances its stability. It binds to GHRH receptors in the anterior pituitary gland, stimulating the synthesis and release of endogenous growth hormone. The resulting increase in GH and IGF-1 levels promotes lipolysis — particularly in visceral adipose tissue — improves lipid profiles, and supports metabolic function without the risks associated with direct GH administration.
Clinical evidence
Tesamorelin has been evaluated in multiple large-scale randomized controlled trials. Studies demonstrated a significant reduction in visceral adipose tissue (up to 18% reduction) over 26 weeks of treatment. Additionally, trials showed improvements in triglyceride levels, trunk fat, and waist circumference. Tesamorelin has received FDA approval for the reduction of excess abdominal fat in HIV-associated lipodystrophy, providing a robust clinical evidence base.
Benefits
Stimulates natural GH production
Works through your body's own growth hormone pathways rather than introducing synthetic GH.
Improves lipid profiles
Studies show improvements in triglycerides and other cardiovascular risk markers.
Well-characterized safety profile
Extensively studied in clinical trials with a well-documented safety record.
Targets visceral fat
Specifically reduces abdominal visceral adipose tissue through enhanced lipolysis.
Stimulates natural GH production
Works through your body's own growth hormone pathways rather than introducing synthetic GH.
Improves lipid profiles
Studies show improvements in triglycerides and other cardiovascular risk markers.
Well-characterized safety profile
Extensively studied in clinical trials with a well-documented safety record.
Key takeaways
- GHRH analog with FDA-studied efficacy for visceral fat reduction
- Up to 18% reduction in visceral adipose tissue in clinical trials
- Stimulates natural growth hormone production
- Improves lipid profiles and metabolic markers
- Daily subcutaneous injection with established dosing protocols
Bundle savings
Savings apply when multiple peptides are prescribed.
| BUNDLE SIZE | INCLUDED | SAVINGS |
|---|---|---|
| 2 Peptides | Simple paired therapy | SAVE 20• |
| 3 Peptides | Multi-pathway plan | SAVE 30• |
| 4 Peptides | Full personalized set | BEST VALUE |
• Results vary. Prescribed only when clinically appropriate.
Peptide Library
Each plan may include several of the following formulations.
The science behind it
Proven science
Every peptide we offer is backed by peer-reviewed research and clinical data. Our medical team stays current with the latest findings to ensure your protocol reflects the best available science.
Discreet delivery
Your medications arrive in unmarked, temperature-controlled packaging shipped directly from licensed compounding pharmacies. Privacy and quality guaranteed at every step.
Doctor-supervised safety
Every treatment is prescribed and monitored by a licensed physician. Regular check-ins, lab reviews, and dosage adjustments ensure your peptide therapy is safe and effective throughout your journey.
Clinician-Led Care
Eligibility check
Quick online assessment
Consultation
Licensed provider reviews your medical history
Prescription
Medication shipped directly once approved
Follow-ups
Ongoing support and check-ins
Eligibility check
Quick online assessment
Consultation
Licensed provider reviews your medical history
Prescription
Medication shipped directly once approved
Follow-ups
Ongoing support and check-ins
Secure telehealth · GDPR-compliant · Pharmacy-grade compounding.
Check eligibility →
Not for self-administration. Reviewed by a medical provider.
Medication made affordable
Capsules
$179/mo
Single Peptide
$229/mo
Double Combo
$349/mo
Triple Combo
$479/mo
Capsules
$179/mo
Single Peptide
$229/mo
Double Combo
$349/mo
Triple Combo
$479/mo
All plans include a doctor review, personalized treatment plan (if approved), and 24/7 access to a licensed provider in your state.
Related treatments
METABOLIC
GLP-1 Therapy
Clinically studied peptides designed to target metabolism, recovery, energy, and longevity.
Learn more →RECOVERY
CJC/Ipamorelin
Stimulate natural growth hormone release for recovery, sleep, and body composition.
Learn more →METABOLIC
AOD-9604
The fat-burning fragment of growth hormone for targeted weight management.
Learn more →Frequently asked questions
Tesamorelin is specifically designed and studied for visceral fat reduction. Unlike general GH secretagogues, it has been evaluated in large-scale clinical trials with FDA oversight, providing a robust evidence base for its metabolic benefits.
Tesamorelin has received FDA approval for the reduction of excess abdominal fat in specific clinical populations. When prescribed by Peppy providers, it is compounded for individual patient use based on clinical assessment.
Clinical trials showed measurable reductions in visceral fat within 12-26 weeks of consistent daily use. Individual results vary based on factors including diet, exercise, and baseline health status.
Tesamorelin primarily targets visceral fat through growth hormone-mediated lipolysis. Some patients report improvements in lean body composition, though it is not specifically indicated for muscle building.
The most frequently reported side effects include injection site reactions, joint pain, and peripheral edema. These are generally mild and manageable. Your provider will monitor for any adverse effects throughout treatment.
Begin your health journey today
Doctor-guided peptide treatments personalized to your health goals. Start with a free consultation
Starting at
$179/month
All plans include doctor review, personalized treatment plan, and 24/7 provider access.